Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Respiratory Combination Vaccine Candidates in Older Adults

NCT05788237 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT05788237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05788237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Respiratory Combination Vaccine Candidates in Older Adults
Lead sponsor
Pfizer
Phase
Phase 1
Overall status
Completed
Start date
March 9, 2023
Completion date
September 27, 2023
Enrollment
508 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy